Sexual Health Preliminary Evidence
Melanotan II
Melanotan II
1 min read
Regulatory Status
🇺🇸 United States
Grey Area Often cited in safety discussions because of adverse-effect and misuse concerns.
FDA · Updated Apr 2026
🇬🇧 United Kingdom
Research Use Only Frequently treated as a research-only compound.
MHRA · Updated Apr 2026
🇦🇺 Australia
Restricted Commercial use and import treatment remains sensitive.
TGA · Updated Apr 2026
🏅 WADA
Not Assessed Not specifically addressed in the current WADA notes used here.
WADA · Updated Apr 2026
Overview
Melanotan II is one of the most controversial peptides in the commercial market because demand is often driven by tanning claims rather than a robust clinical evidence base. It frequently appears in safety-centered regulatory discussions.
Continue Reading